Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. - Wikidata - wikimedia - TriplyDB

Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.

Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.

http://www.wikidata.org/entity/Q34760295

about

Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes.Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.Caution with Use of the Expanded Prostate Cancer Index Composite-50 Urinary Bother Scale: How Voiding Dysfunction Modifies Its Performance.Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications.Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalized Prostate Cancer Survivorship Care: Protocol for a Realist Case Study of the Ned App.Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations.Racial or Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-specific Quality of Life.Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.A prospective study of the short-term quality-of-life outcomes of patients undergoing transperineal prostate biopsy.The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England.Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.

P2860

Q33885592-4B443FAF-2760-42CA-AB24-6772AAB39771 Q35233601-9A6DC7D0-9D91-4995-B85E-8BD61B98E9A4 Q37028549-9C5DE655-EF81-4C1B-9E96-114C5DFF8401 Q38890085-E39E3F95-97FE-40B1-9B94-6997582BD839 Q38893692-FF58863B-57EF-46F7-981E-1DE4D83AD977 Q39078034-A149E4E9-43B9-4417-BECD-EDA79C8CFE1A Q39167790-5D0D623B-0F74-4AEF-BD3F-68C773BCE1D7 Q39212848-90E0AA25-AA0E-4D1C-A0BF-05D43C00BE41 Q40045900-3297E117-94D3-4761-AECB-B1144306BF93 Q40114337-EF03F778-E760-4FF7-8D0D-554E17681053 Q40738407-E1E30369-30C0-48D9-9B5C-A39ACCCFE688 Q46110279-3ED75E21-F952-4320-A15D-52FF97959CE3 Q47098140-2A483B7A-6CCF-42D6-9889-1EA0D6D3C9AC Q47142153-12591E7D-9DE8-4C04-B84B-736B0711D500 Q47713178-1541D815-D92E-4C54-9274-EDEB9672135F Q47814944-66F97044-CF02-4FC3-8F85-1873CEF5AF2B Q47853134-63C1EA5A-45E4-44DD-9FBC-59DAED5092A4 Q49842898-95288971-D1A6-41D4-AEEB-F9AEA13B4454 Q49952107-E436FB29-2412-4C11-B2E1-EC3073C1762E Q50141373-6A2441CF-39D5-4AD3-ADDE-5056D22D297E

P2860

Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.

http://www.wikidata.org/entity/Q34760295

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Minimally important difference ...... er Index Composite Short Form.

@ast

Minimally important difference ...... er Index Composite Short Form.

@en

Minimally important difference ...... er Index Composite Short Form.

@nl

type

label

Minimally important difference ...... er Index Composite Short Form.

@ast

Minimally important difference ...... er Index Composite Short Form.

@en

Minimally important difference ...... er Index Composite Short Form.

@nl

prefLabel

Minimally important difference ...... er Index Composite Short Form.

@ast

Minimally important difference ...... er Index Composite Short Form.

@en

Minimally important difference ...... er Index Composite Short Form.

@nl

P1433

Q34760295-41A55E30-D1C9-488C-A240-31017BDB1CF5

P1476

Q34760295-25358AC0-16C6-4DC8-AF8F-F62EB99E916D

P2093

Q34760295-32B72E48-4C33-4FB4-B458-3BFE159DABFE

Q34760295-3EA5880B-3C71-4500-9BFA-9D25AA193D68

Q34760295-56085CC3-3920-4572-83A1-193E0B76BD48

Q34760295-726D2076-00DB-44E5-AFF5-9574B7024FD5

Q34760295-871A451F-2888-43CF-8B06-980BC1F26C6B

Q34760295-A07625D7-B057-49E9-9FA1-2397444C3095

Q34760295-D0C06B9D-8351-4F35-8386-565E7EB99030

Q34760295-F90EF12C-8E17-436C-9072-AC639DEE2A57

P2860

Q34760295-25F15FB6-AE1C-4151-8EED-08AA5595F1AC

Q34760295-2D4BEE5C-2900-4C50-9660-42315824E20F

Q34760295-3DB45735-3034-4AE0-B829-6BC9761A66CA

Q34760295-5462A77D-A648-402C-A4FB-A417DD9543A0

Q34760295-64E8F3C8-7F37-4E78-B2FF-F3B809F2AB34

Q34760295-674CF74E-52B2-44D5-BB55-E6C36271D4D2

Q34760295-7AAEC6C2-D18A-47FE-8775-F9182D1BE02B

Q34760295-7CF74128-D0F2-4C9A-853B-9C640ECE859D

Q34760295-86A78227-332C-46C1-B407-569B8AC463CC

Q34760295-A291929C-F1AB-4910-9B8C-50D05B564D43

P304

Q34760295-ED1E1C53-E015-424C-83E2-CECAA8931A44

P31

Q34760295-0971611B-27FA-4E4B-AD91-50271655A37D

P356

Q34760295-C8BB0EC6-6490-480E-A389-D1FCEC170FEE

P407

Q34760295-E1B36823-B616-4686-B57E-A51071441301

P433

Q34760295-C9902509-79D2-4B1E-80B5-B02D7BE5A6EB

P478

Q34760295-2BB3981F-3C4A-4EB1-8BD5-02F443CECE74

P577

Q34760295-E36AF164-A5AB-4DD2-A3CD-6E377EF06B0A

P698

Q34760295-EDC7EADB-3F74-48AD-83C9-4CC08B881A49

P932

Q34760295-B55A9585-09FA-44CC-9632-F683D7D834C6

P356

J.UROLOGY.2014.08.044

P1433

P1476

Minimally important difference ...... er Index Composite Short Form.

@en

P2093

John T Wei

http://www.w3.org/2001/XMLSchema#string

Mark S Litwin

http://www.w3.org/2001/XMLSchema#string

Martin G Sanda

http://www.w3.org/2001/XMLSchema#string

PROSTQA Consortium

http://www.w3.org/2001/XMLSchema#string

Peter Chang

http://www.w3.org/2001/XMLSchema#string

Rodney L Dunn

http://www.w3.org/2001/XMLSchema#string

Ted A Skolarus

http://www.w3.org/2001/XMLSchema#string

Thomas K Greenfield

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative effectiveness of external-beam radiation approaches for prostate cancer.

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

Active surveillance for early-stage prostate cancer: review of the current literature.

Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer.

Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.

Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.

Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors.

P304

101-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLOGY.2014.08.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25530370

http://www.w3.org/2001/XMLSchema#string

P932

4274392

http://www.w3.org/2001/XMLSchema#string